MRK - Merck

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Susan Monarez wins Senate confirmation as CDC director
• FDA vaccines head, chief medical officer Vinay Prasad departs agency
• Merck outlines $3B reinvestment initiative and expects 1%–2% revenue growth for 2025 while advancing new product launches
• EU pharma lobby criticizes potential Trump tariffs on pharmaceuticals
• Biggest stock movers Tuesday: SOFI, UNH, TLRY, PHG, and more
• Merck in Charts: KEYTRUDA sales surge 9% Y/Y, GARDASIL dips 54% in Q2
• Merck plans $3B annual cost cuts as Keytruda faces patent cliff
• Merck Non-GAAP EPS of $2.13 beats by $0.10, revenue of $15.81B misses by $60M
• RFK Jr. seeks to 'fix' Vaccine Injury Compensation Program
• Merck Q2 Earnings Preview: What to expect?
• Merck declares $0.81 dividend
• Former biotech exec George Tidmarsh to lead key FDA drug center
• Bristol Myers fails in late-stage trial for Merck-partnered anemia therapy in blood cancer
• Trump eyes drug, chip tariffs by month-end
• Merck to begin late-stage trials for HIV prevention pill
• Key deals this week: Meta, Boyd Gaming, Merck, Sandstorm Gold, Capgemini and more
• FDA mulls faster drug reviews in exchange for lower prices in U.S.- Bloomberg
• Merck Animal Health gets FDA nod for Bravecto Quantum
• FDA publishes more than 200 rejection letters in a bid to improve transparency
• Merck's doravirine/islatravir under FDA review for HIV